Latest Revenue Growth News

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

Cochlear Limited has secured FDA approval for its latest Nucleus Nexa System and Kanso 3 sound processors, setting the stage for a US market debut in early FY26.

Netlinkz Limited reports $4.8 million in quarterly customer receipts, exits Starlink operations, and pivots to a joint venture in the Philippines to drive growth across ASEAN markets.

Pact Group Holdings confirms its voluntary delisting from the ASX effective mid-July, alongside a provisional FY25 trading update showing slight revenue growth driven by its Materials Handling segment.

Locate Technologies has successfully raised nearly $400,000 through its ATM facility, bolstering its cash reserves to support growth in its delivery optimisation platforms.

Nanosonics has launched trophon3, its next-generation ultrasound disinfection device, alongside a software upgrade for existing users, promising faster cycles and enhanced digital integration.

RPMGlobal reports a strong 30.9% rise in software sales for FY2025, driven by subscription growth, with recurring revenue and backlog reaching new highs.

Cleanaway Waste Management has secured regulatory approval to acquire Contract Resources, positioning itself as a leader in specialised industrial waste services. The deal, set to complete by the end of July, aims to accelerate growth in the decommissioning and remediation market.

Enlitic has completed its $10 million capital raise, triggering a $2 million advance payment from GE HealthCare and cementing a strategic collaboration with significant revenue potential.

Tourism Holdings Limited trims its FY25 profit guidance to the lower end of analyst expectations, citing ongoing challenges in global RV sales and a potential goodwill impairment tied to its US operations.

Stealth Group Holdings has secured exclusive distribution rights for major global consumer brands in Australia and New Zealand, aiming to accelerate revenue growth and expand its digital footprint.

PainChek Limited reports a robust quarter with a 10% rise in annual recurring revenue and expanding global client base, underpinned by strong licence retention and positive clinical validation.